Garriga-Baraut, T.; Labrador-Horrillo, M.; Tena, M.; De Linares, C.; Esteso-Hontoria, O.; Pedemonte, C.; Basagaña-Torrento, M.; Miquel, S.; Padró-Casas, C.; Campa-Falcon, N.; Ferré-Ybarz, L.; Gázquez-Garcia, V.; Muñoz-Cano, R.; Viñas, M.; Farrarons, L.; Baltasar-Dragó, M.; Cortés, N.; Asensio, O.; Bartra, J.; Belmonte, J.; Bobolea, I.; Raga, E.; Miguel Moncín, M. S. A Real-Life ImmunoCAT Study: Impact of Molecular Diagnosis through ImmunoCAPTM ISAC 112 on Immunotherapy Prescription in Pollen-Polysensitized Patients in Catalonia, Spain. Allergol Immunopathol 2024, 52 (4), 21-29. https://doi.org/10.15586/aei.v52i4.1077.